# Docohexanoic Acid in Hemodialysis Patients

> **NCT04536636** · NA · COMPLETED · sponsor: **Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal** · enrollment: 42 (actual)

## Conditions studied

- Chronic Renal Failure

## Interventions

- **DRUG:** Docohexanoic acid
- **DRUG:** Control-No drug

## Key facts

- **NCT ID:** NCT04536636
- **Lead sponsor:** Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-01
- **Primary completion:** 2018-09-30
- **Final completion:** 2018-09-30
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2020-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04536636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04536636, "Docohexanoic Acid in Hemodialysis Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04536636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*